Clinical implications of EGFR-associated MAPK/ERK pathway in multiple primary lung cancer

Clin Transl Med. 2022 May;12(5):e847. doi: 10.1002/ctm2.847.

Naixin Liang¹, Zhongxing Bing¹, Yadong Wang^{1

2}, Xinyu Liu¹, Chao Guo¹, Lei Cao¹, Yuan Xu¹, Yang Song¹, Chao Gao¹, Zhenhuan Tian¹, Pancheng Wu^{1

2}, Jianchao Xue^{1

2}, Bowen Li^{1

2}, Ziqi Jia^{1

3}, Xiaoying Yang^{1

3}, Yijun Wu^{1

3}, Ruoying Yu⁴, Rui Liu⁴, Xiaoxi Chen⁴, Qiuxiang Ou⁴, Hua Bao⁴, Xue Wu⁴, Zhili Cao¹, Ji Li⁵, Shanqing Li¹

¹ Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
² Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
³ Peking Union Medical College, Eight-Year MD Program, Chinese Academy of Medical Sciences, Beijing, China.
⁴ Nanjing Geneseeq Technology Inc., Nanjing, China.
⁵ Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.

No abstract available

Publication types